Norio Shiba

1.9k total citations
40 papers, 533 citations indexed

About

Norio Shiba is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Norio Shiba has authored 40 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 13 papers in Molecular Biology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Norio Shiba's work include Acute Myeloid Leukemia Research (32 papers), Acute Lymphoblastic Leukemia research (13 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Norio Shiba is often cited by papers focused on Acute Myeloid Leukemia Research (32 papers), Acute Lymphoblastic Leukemia research (13 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Norio Shiba collaborates with scholars based in Japan, Sweden and United States. Norio Shiba's co-authors include Yasuhide Hayashi, Hirokazu Arakawa, Keizo Horibe, Souichi Adachi, Hyuntae Park, Akio Tawa, Daisuke Tomizawa, Seishi Ogawa, Takashi Taga and Yusuke Hara and has published in prestigious journals such as Nucleic Acids Research, Blood and British Journal of Haematology.

In The Last Decade

Norio Shiba

37 papers receiving 525 citations

Peers

Countries citing papers authored by Norio Shiba

Since Specialization

Citations

This map shows the geographic impact of Norio Shiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norio Shiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norio Shiba more than expected).

Fields of papers citing papers by Norio Shiba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norio Shiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norio Shiba. The network helps show where Norio Shiba may publish in the future.

Co-authorship network of co-authors of Norio Shiba

This figure shows the co-authorship network connecting the top 25 collaborators of Norio Shiba. A scholar is included among the top collaborators of Norio Shiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norio Shiba. Norio Shiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adverse prognostic impact of <i>KIT</i> exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with <i>RUNX1::RUNX1T1</i> 2024 ·Haematologica ·Shota Kato, Shin‐ichi Tsujimoto, Jun Matsubayashi, Shotaro Iwamoto, Hidefumi Hiramatsu, Yusuke Okuno, (unknown), Kentaro Ohki, Takao Deguchi, Nobutaka Kiyokawa, Motohiro Kato, Junko Takita, Shiro Tanaka, Souichi Adachi, Daisuke Tomizawa, Norio Shiba	0
2	Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia 2024 ·Molecular Biomedicine ·(unknown), (unknown), Norio Shiba, Daisuke Tomizawa, Yasuhide Hayashi, Seishi Ogawa, Li Chen, Hua You	3
3	High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05 trial 2024 ·Pediatric Blood & Cancer ·(unknown), Shin‐ichi Tsujimoto, (unknown), Tomoko Kawai, Kentaro Ohki, Yusuke Hara, Genki Yamato, Reo Tanoshima, Daisuke Tomizawa, Akira Shimada, Keizo Horibe, Souichi Adachi, Takashi Taga, Akio Tawa, Yasuhide Hayashi, Shuichi Ito, Norio Shiba	1
4	Cytokine profiling in 128 patients with transient abnormal myelopoiesis: a report from the JPLSG TAM-10 trial 2024 ·Blood Advances ·Genki Yamato, (unknown), Hideki Muramatsu, Akira Shimada, Takahiro Imaizumi, Hiroyuki Tsukagoshi, (unknown), Norio Shiba, Yoshiyuki Yamada, Takao Deguchi, Tomoko Kawai, Kiminori Terui, Etsuro Ito, Kenichiro Watanabe, Yasuhide Hayashi	0
5	NPM1-fusion proteins promote myeloid leukemogenesis through XPO1-dependent HOX activation 2024 ·Leukemia ·(unknown), (unknown), (unknown), Wenyu Zhang, Norio Shiba, Yasuhide Hayashi, Shuichi Ito, Toshio Kitamura, Susumu Goyama	6
6	High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core‐binding factor 2023 ·Pediatric Blood & Cancer ·Takahiro Aoki, Norio Shiba, Shin‐ichi Tsujimoto, Genki Yamato, Yusuke Hara, Shota Kato, Kenichi Yoshida, Seishi Ogawa, Yasuhide Hayashi, Shotaro Iwamoto, Tomohiko Taki, Akira Shimada, Yuka Iijima‐Yamashita, Keizo Horibe, Akio Tawa, Takashi Taga, Souichi Adachi, Daisuke Tomizawa	5
7	The Nup98::Nsd1 fusion gene induces CD123 expression in 32D cells 2023 ·International Journal of Hematology ·Kenji Okamoto, Toshihiko Imamura, Seiji Tanaka, (unknown), Hideki Yoshida, Norio Shiba, Tomoko Iehara	4
8	Comprehensive molecular understanding of pediatric acute myeloid leukemia 2023 ·International Journal of Hematology ·Norio Shiba	9
9	The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05R study 2020 ·Pediatric Blood & Cancer ·Hiroshi Moritake, Shiro Tanaka, Takako Miyamura, Hideki Nakayama, Norio Shiba, Akira Shimada, Kiminori Terui, Yuki Yuza, Katsuyoshi Koh, Hiroaki Goto, Harumi Kakuda, Akiko Saito, Daisuke Hasegawa, Shotaro Iwamoto, Takashi Taga, Souichi Adachi, Daisuke Tomizawa	12
10	Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML‐05 study 2019 ·British Journal of Haematology ·Takako Miyamura, Hiroshi Moritake, Hideki Nakayama, Shiro Tanaka, Daisuke Tomizawa, Norio Shiba, Akiko Saito, Akio Tawa, Akira Shimada, Shotaro Iwamoto, Yasuhide Hayashi, Takashi Koike, Keizo Horibe, Atsushi Manabe, Shuki Mizutani, Takashi Taga, Souichi Adachi	15
11	Negative CD19 expression is associated with inferior relapse‐free survival in children with RUNX1‐RUNX1T1–positive acute myeloid leukaemia: results from the Japanese Paediatric Leukaemia/Lymphoma Study Group AML‐05 study 2019 ·British Journal of Haematology ·Kenichi Sakamoto, Norio Shiba, Takao Deguchi, Nobutaka Kiyokawa, Yoshiko Hashii, (unknown), Daisuke Tomizawa, Takashi Taga, (unknown), Keizo Horibe, Toshihiko Imamura	9
12	Allogeneic Bone Marrow Transplantation versus Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies in Children: A Systematic Review and Meta-Analysis 2019 ·Biology of Blood and Marrow Transplantation ·(unknown), Reo Tanoshima, Shin‐ichi Tsujimoto, Masanobu Takeuchi, Norio Shiba, Tohru Kobayashi, Shuichi Ito	15
13	Whole transcriptome sequencing reveals a KMT2A‐USP2 fusion in infant acute myeloid leukemia 2019 ·Genes Chromosomes and Cancer ·(unknown), Norio Shiba, Shin‐ichi Tsujimoto, Masanori Yoshida, Kazuhiko Nakabayashi, Hiroko Ogata‐Kawata, K. Okamura, Masanobu Takeuchi, Tomoo Osumi, Daisuke Tomizawa, Kenichiro Hata, Nobutaka Kiyokawa, Shuichi Ito, Motohiro Kato	8
14	Comparison of conditioning regimens for autologous stem cell transplantation in children with acute myeloid leukemia: A nationwide retrospective study in Japan 2018 ·Pediatric Blood & Cancer ·Hirotoshi Sakaguchi, Hideki Muramatsu, Daiichiro Hasegawa, Kazuko Kudo, Hiroyuki Ishida, Nao Yoshida, Katsuyoshi Koh, Maiko Noguchi, Norio Shiba, Sadao Tokimasa, (unknown), Hiroaki Goto, Takako Miyamura, Yozo Nakazawa, Yoshiko Hashii, Masami Inoue, Yoshiko Atsuta, (unknown)	6
15	Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases 2018 ·Bone Marrow Transplantation ·Daisuke Tomizawa, Masanori Yoshida, Tadakazu Kondo, Takako Miyamura, Takashi Taga, Souichi Adachi, Katsuyoshi Koh, Maiko Noguchi, Harumi Kakuda, Kenichiro Watanabe, Yuko Cho, Takahiro Fukuda, Motohiro Kato, Norio Shiba, Hiroaki Goto, Keiko Okada, Masami Inoue, Yoshiko Hashii, Yoshiko Atsuta, Hiroyuki Ishida	13
16	Effect of Age on the Prognosis of Molecular Abnormalities in Pediatric Acute Myeloid Leukemia 2018 ·Blood ·Yusuke Hara, Norio Shiba, Genki Yamato, Kentaro Ohki, Manabu Sotomatsu, Ken Tabuchi, Daisuke Tomizawa, Tomohiko Taki, Akitoshi Kinoshita, Nobutaka Kiyokawa, Hirokazu Arakawa, Masabumi Shibuya, Takashi Taga, Akio Tawa, Keizo Horibe, Souichi Adachi, Yasuhide Hayashi	0
17	High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML 2015 ·Leukemia ·(unknown), Sachiyo Mitani, Norio Shiba, Y Hayashi, Yusuke Hara, Hiro Takahashi, Ichiro Tsukimoto, Akio Tawa, Keizo Horibe, Daisuke Tomizawa, Takashi Taga, Souichi Adachi, Tetsuya Yoshida, Hitoshi Ichikawa	37
18	Poor Prognosis Associated with FAB Subtypes M4 and M5 in Japanese Pediatric Acute Myeloid Leukemia Patients with FLT3-ITD 2014 ·Blood ·Yusuke Hara, Norio Shiba, Kentaro Ohki, Hyuntae Park, Akira Shimada, Daisuke Tomizawa, Akiko Saito, Junichiro Fujimoto, Tomohiko Taki, Akitoshi Kinoshita, Takashi Taga, Hirokazu Arakawa, Akio Tawa, Keizo Horibe, Souichi Adachi, Yasuhide Hayashi	1
19	An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data 2013 ·Nucleic Acids Research ·Yuichi Shiraishi, Yusuke Sato, Kenichi Chiba, Yusuke Okuno, Yasunobu Nagata, Kenichi Yoshida, Norio Shiba, Yasuhide Hayashi, Haruki Kume, Yukio Homma, Masashi Sanada, Seishi Ogawa, Satoru Miyano	107
20	NOTCH1 mutation in a female with myeloid/NK cell precursor acute leukemia 2010 ·Pediatric Blood & Cancer ·Norio Shiba, Takashi Kanazawa, Hyuntae Park, (unknown), Kazushi Tamura, (unknown), Yasuhide Hayashi, Hirokazu Arakawa	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact